Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.14 USD | +1.79% | +4.09% | +53.30% |
05-02 | Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss | MT |
05-02 | Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.30% | 1.94B | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- Canaccord Genuity Adjusts Agios Pharmaceuticals' Price Target to $52 From $65, Keeps Buy Rating